Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ZMYND8 Protein, N-His

Catalog #:   YHK64501 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9ULU4
Protein length: His111-Thr388
Overview

Catalog No.

YHK64501

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

His111-Thr388

Predicted molecular weight

34.44 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9ULU4

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Protein kinase C-binding protein 1, PRKCBP1, RACK7, ZMYND8, CTCL-associated antigen se14-3, Cutaneous T-cell lymphoma-associated antigen se14-3, Rack7, KIAA1125, Zinc finger MYND domain-containing protein 8

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human ZMYND8 Protein
References

HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury., PMID:40403721

ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways., PMID:40347515

ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27., PMID:40281007

The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8., PMID:40223119

RACK7 Interacts with PRC2 Complex to Regulate Astrocyte Development., PMID:40125808

Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer., PMID:40102673

ABL Kinases Modulate EZH2 Phosphorylation and Signaling in Metastatic Triple Negative Breast Cancer., PMID:40027835

Catalytic-independent functions of the Integrator-PP2A complex (INTAC) confer sensitivity to BET inhibition., PMID:39809894

Gender-different effect of Src family kinases antagonism on photophobia and trigeminal ganglion activity., PMID:39390364

USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion., PMID:39128723

The Molecular and Biological Function of MEF2D in Leukemia., PMID:39017853

Basis of gene-specific transcription regulation by the Integrator complex., PMID:38906142

Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer., PMID:38853277

ZMYND8 Is a Regulator of Sonic Hedgehog Signaling in ATRA-Mediated Differentiation of Neuroblastoma Cells., PMID:38804064

ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2., PMID:38488001

Radiosensitization of IDH-Mutated Gliomas through ZMYND8 - a Pathway to Improved Outcomes., PMID:36826993

Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance., PMID:36692427

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma., PMID:36438198

CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma., PMID:36306724

Pseudotime analysis reveals novel regulatory factors for multigenic onset and monogenic transition of odorant receptor expression., PMID:36171231

ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers., PMID:36153585

ZMYND8 suppresses MAPT213 LncRNA transcription to promote neuronal differentiation., PMID:36064715

De Novo ZMYND8 variants result in an autosomal dominant neurodevelopmental disorder with cardiac malformations., PMID:35916866

Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers., PMID:35290241

ZMYND8 mediated liquid condensates spatiotemporally decommission the latent super-enhancers during macrophage polarization., PMID:34764296

Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer., PMID:34487730

Exploiting a key transcriptional dependency: ZMYND8 and IRF8 in AML., PMID:34478652

Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma., PMID:34462784

ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency., PMID:34358447

The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis., PMID:33977073

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability., PMID:33932349

Regulation of ZMYND8 to Treat Cancer., PMID:33670804

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer., PMID:33593912

ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis., PMID:33517164

Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization., PMID:33323928

ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth., PMID:33148660

RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma., PMID:32832624

Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT., PMID:32564755

A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders., PMID:32530565

Relationship among DNA double-strand break (DSB), DSB repair, and transcription prevents genome instability and cancer., PMID:32232911

ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis., PMID:32224527

A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual-histone binding function., PMID:31965980

Mapping Bromodomains in breast cancer and association with clinical outcome., PMID:30952871

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation., PMID:30854423

Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart., PMID:30395227

The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination., PMID:30293785

"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism., PMID:30139738

Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex., PMID:30134174

ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis., PMID:29629903

Double duty: ZMYND8 in the DNA damage response and cancer., PMID:29393731

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ZMYND8 Protein, N-His [YHK64501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only